Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Levy Richard S
Relationship:  
City:   Wilmington
State:   DE
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   67,748    

Indirect Shares

   0      
Direct Value   $3,781,353    

Indirect Value

   $0      
Total Shares   67,748      
Total Value   $3,781,353      


Incyte Corp $995,249 Madrigal Pharmaceuticals Inc $2,528,056 Protara Therapeutics, Inc $86,800 Kodiak Sciences Inc. $3,240 Kiniksa Pharmaceuticals, Ltd. $168,008 Incyte Corp $995,249 Madrigal Pharmaceuticals Inc $2,528,056 Protara Therapeutics, Inc $86,800 Kodiak Sciences Inc. $3,240 Kiniksa Pharmaceuticals, Ltd. $168,008
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   195.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY EVP, Chief Drug Dev Of... 2016-01-06 16,926 2010-03-15 0    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-04-01 10,298 2017-08-21 0    Premium*  
            Protara Therapeutics, Inc TARA Director 2020-01-10 31,000 2020-01-10 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-03-20 1,000 2020-03-20 0    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 2024-05-03 8,524 2023-06-29 0    Premium*  
* Premium Members only  

Records found :    81         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-02-17 4 OE $14.72 $187,947 D/D 12,000 30,205 0 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2017-08-21 4 B $15.67 $56,358 D/D 3,550 3,550 2.39 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2011-01-18 4 AS $15.77 $636,847 D/D (40,310) 0 0 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2017-08-22 4 B $15.99 $57,209 D/D 3,550 7,100 2.39 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2017-08-23 4 B $16.08 $32,236 D/D 2,000 9,100 2.39 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-06-19 4 OE $17.79 $355,800 D/D 20,000 41,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-07-15 4 OE $17.79 $1,249,160 D/D 70,217 91,444 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-01-06 4 OE $18.32 $458,000 D/D 25,000 43,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-02-06 4 OE $18.32 $458,000 D/D 25,000 43,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-03-06 4 OE $18.32 $458,000 D/D 25,000 46,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-04-06 4 OE $18.32 $458,000 D/D 25,000 46,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-05-06 4 OE $18.32 $135,788 D/D 7,412 28,639 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-06-08 4 OE $18.32 $72,126 D/D 3,937 25,164 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-07-06 4 OE $18.32 $72,126 D/D 3,937 25,164 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-08-06 4 OE $18.32 $72,108 D/D 3,936 25,163 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-09-08 4 OE $18.32 $72,126 D/D 3,937 25,164 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-10-06 4 OE $18.32 $72,126 D/D 3,937 20,863 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-11-06 4 OE $18.32 $72,108 D/D 3,936 20,862 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-12-07 4 OE $18.32 $72,126 D/D 3,937 20,863 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2016-01-06 4 OE $18.32 $72,126 D/D 3,937 20,863 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-05-13 4 S $22.30 $1,242,088 D/D (55,699) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-02-15 4 S $22.48 $2,212,931 D/D (98,440) 0 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2012-04-27 4 AS $22.95 $688,500 D/D (30,000) 0 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-09-06 4 S $35.28 $882,000 D/D (25,000) 0 0 -
KOD Kodiak Sciences Inc. Director   –       •      –    2020-03-20 4 B $43.37 $44,330 D/D 1,000 1,000 2.39 %
  81  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us